Yuichi Iwaki
Net Worth
Last updated:
What is Yuichi Iwaki net worth?
The estimated net worth of Dr. Yuichi Iwaki is at least $16,641,408 as of 9 Jul 2021. He owns shares worth $1,014,888 as insider and has received compensation worth at least $15,626,520 in MediciNova, Inc..
What is the salary of Yuichi Iwaki?
Dr. Yuichi Iwaki salary is $868,140 per year as Co-Founder, Pres, Chief Executive Officer & Executive Director in MediciNova, Inc..
How old is Yuichi Iwaki?
Dr. Yuichi Iwaki is 75 years old, born in 1950.
What stocks does Yuichi Iwaki currently own?
As insider, Dr. Yuichi Iwaki owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
MediciNova, Inc. (MNOV) | Co-Founder, Pres, Chief Executive Officer & Executive Director | 780,683 | $1.3 | $1,014,888 |
What does MediciNova, Inc. do?
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Yuichi Iwaki insider trading
MediciNova, Inc.
MediciNova key executives
MediciNova, Inc. executives and other stock owners filed with the SEC:
- Dr. Kazuko Matsuda M.P.H., M.D., Ph.D., MPH (59) Chief Medical Officer & Director
- Dr. Yuichi Iwaki (75) Co-Founder, Pres, Chief Executive Officer & Executive Director